Benefits and problems of allogeneic stem cell transplantation as multiple myeloma treatment

Share :
Published: 1 Nov 2016
Views: 3106
Prof Nicolaus Kröger - University Hospital Hamburg, Hamburg, Germany

Prof Kröger talks to ecancertv at ICMM 2016 about the standard treatment of multiple myeloma in younger patients.

In particular, he highlights both the benefits and complications associated with allogeneic stem cell transplants.

ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.